Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.

Cell metabolism | 2019

Regulatory T (Treg) cells induce an immunosuppressive microenvironment that is a major obstacle for successful tumor immunotherapy. Dissecting the regulatory mechanisms between energy metabolism and functionality in Treg cells will provide insight toward developing novel immunotherapies against cancer. Here we report that human naturally occurring and tumor-associated Treg cells exhibit distinct metabolic profiles with selectivity for glucose metabolism compared with effector T cells. Treg-mediated accelerated glucose consumption induces cellular senescence and suppression of responder T cells through cross-talk. TLR8 signaling selectively inhibits glucose uptake and glycolysis in human Treg cells, resulting in reversal of Treg suppression. Importantly, TLR8 signaling-mediated reprogramming of glucose metabolism and function in human Treg cells can enhance anti-tumor immunity in vivo in a melanoma adoptive transfer T cell therapy model. Our studies identify mechanistic links between innate signaling and metabolic regulation of human Treg suppression, which may be used as a strategy to advance tumor immunotherapy.

Pubmed ID: 30344014 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HIF1A Polyclonal Antibody (antibody)

RRID:AB_2117128

This unknown targets HIF1A

View all literature mentions

Glut3 (H-50) (antibody)

RRID:AB_2254979

This polyclonal targets SLC2A3

View all literature mentions

Glut1 (H-43) (antibody)

RRID:AB_2190936

This polyclonal targets SLC2A1

View all literature mentions

Anti-4E-BP1, phospho (Thr37 / Thr46) Monoclonal Antibody (antibody)

RRID:AB_560835

This monoclonal targets 4E-BP1, phospho (Thr37 / Thr46)

View all literature mentions

Phospho-p70 S6 Kinase (Thr389) (108D2) Rabbit mAb (antibody)

RRID:AB_2269803

This monoclonal targets p70 S6 Kinase, phospho (Thr389)

View all literature mentions

Phospho-mTOR (Ser2448) Antibody (antibody)

RRID:AB_330970

This polyclonal targets Phospho-mTOR (Ser2448)

View all literature mentions

InVivoMab anti-human IFNγ (antibody)

RRID:AB_2687717

This monoclonal targets IFNγ

View all literature mentions

InVivoMab anti-human IL-4 (antibody)

RRID:AB_2687722

This monoclonal targets IL-4

View all literature mentions

InVivoMab anti-human CD28 (antibody)

RRID:AB_2687729

This monoclonal targets CD28

View all literature mentions

InVivoMab anti-human CD3 (antibody)

RRID:AB_1107632

This monoclonal targets CD3

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

FlowJo (software resource)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

NOD.Cg-Prkdcscid Il2rg/SzJ (organism)

RRID:IMSR_JAX:005557

Mus musculus with name NOD.Cg-Prkdcscid Il2rg/SzJ from IMSR.

View all literature mentions